Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Importance of Evaluating Cardiovascular Risk and Hepatic Fibrosis in Patients With Newly Diagnosed Nonalcoholic Fatty Liver Disease.
Moreno-Del Castillo MC, Sanchez-Rodriguez A, Hernandez-Buen Abad JJ, Aguirre-Valadez J, Ruiz I, Garcia-Buen Abad R, Oliva K, Piccolo J, De Icaza-Del Rio E, Mena-Ramirez JR, Mendizabal-Rodriguez ME, Atkinson-Ginsburg NM, Salazar-Segovia J, Ríos-Zertuche Caceres A, Garcia-Juarez I. Moreno-Del Castillo MC, et al. Clin Gastroenterol Hepatol. 2019 Apr;17(5):997-999. doi: 10.1016/j.cgh.2018.07.039. Epub 2018 Aug 2. Clin Gastroenterol Hepatol. 2019. PMID: 30077785
Validation of a novel integral disease index for evaluating the grade of activity in Mexican patients with ulcerative colitis: A prospective cohort study.
Yamamoto-Furusho JK, Bozada-Gutiérrez KE, Sánchez-Rodríguez A, Bojalil-Romano F, Barreto-Zuñiga R, Martínez-Benitez B. Yamamoto-Furusho JK, et al. Rev Gastroenterol Mex (Engl Ed). 2019 Jul-Sep;84(3):317-325. doi: 10.1016/j.rgmx.2018.07.006. Epub 2019 Jan 22. Rev Gastroenterol Mex (Engl Ed). 2019. PMID: 30679027 Free article. English, Spanish.
Impact of glucocorticoid dose on complete response, serious infections, and mortality during the initial therapy of lupus nephritis: A systematic review and meta-analysis of the control arms of randomized controlled trials.
Figueroa-Parra G, Cuéllar-Gutiérrez MC, González-Treviño M, Sanchez-Rodriguez A, Flores-Gouyonnet J, Meade-Aguilar JA, Prokop LJ, Murad MH, Dall'Era M, Rovin BH, Houssiau F, Tamirou F, Fervenza FC, Crowson CS, Putman MS, Duarte-García A. Figueroa-Parra G, et al. Among authors: sanchez rodriguez a. Arthritis Rheumatol. 2024 May 20. doi: 10.1002/art.42920. Online ahead of print. Arthritis Rheumatol. 2024. PMID: 38766897
Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study.
Santos-García D, de Deus T, Cores C, Feal Painceiras MJ, Íñiguez Alvarado MC, Samaniego LB, López Maside A, Jesús S, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández-Vara J, Cabo López I, López Manzanares L, González-Aramburu I, Ávila A, Gómez-Mayordomo V, Nogueira V, Dotor García-Soto J, Borrué-Fernández C, Solano B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Mendoza Z, Pareés I, Sánchez Alonso P, Alonso Losada MG, López-Ariztegui N, Gastón I, Kulisevsky J, Seijo M, Valero C, Alonso Redondo R, Buongiorno MT, Ordás C, Menéndez-González M, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos-García D, et al. Mov Disord Clin Pract. 2024 May 15. doi: 10.1002/mdc3.14056. Online ahead of print. Mov Disord Clin Pract. 2024. PMID: 38747234
Oculomotor Dysfunction in Idiopathic and LRRK2-Parkinson's Disease and At-Risk Individuals.
Lage C, Sánchez-Rodríguez A, Rivera-Sánchez M, Sierra M, González-Aramburu I, Madera J, Delgado-Alvarado M, López-García S, Martínez-Dubarbie F, Fernández-Matarrubia M, Martínez-Amador N, Martínez-Rodríguez I, Calvo-Córdoba A, Rodríguez-Rodríguez E, García-Cena C, Sánchez-Juan P, Infante J. Lage C, et al. Among authors: sanchez rodriguez a. J Parkinsons Dis. 2024 May 2. doi: 10.3233/JPD-230416. Online ahead of print. J Parkinsons Dis. 2024. PMID: 38701160
256 results